Voyager Therapeutics is trading 5.5% down at $3.02 as risk-off sentiment pressures the biotech sector and broader markets.
- The decline extends a multi-day slide, with shares now approaching their recent 52-week low.
- No company-specific news or rating changes were reported today; the move tracks broader losses in the XBI and Nasdaq as investors reduce exposure to high-risk growth stocks.